Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.

Nishioka N, Murata D, Azuma K, Ito K, Nomizo T, Yamada K, Imabayashi T, Iwanaga K, Chibana K, Ota T, Nishii Y, Nakao A, Okada A, Hamai K, Sakai T, Harada T, Tanimura K, Yoshimine K, Tamura Y, Takaki R, Goto Y, Hibino M, Oba T, Sumi T, Kaneda H, Yamada T, Takayama K

Open source

DOI: 10.1007/s10147-026-03157-1
Published: 2026 Aug 4
Container: International journal of clinical oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10147-026-03157-1,
  title = {Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.},
  author = {Nishioka N and Murata D and Azuma K and Ito K and Nomizo T and Yamada K and Imabayashi T and Iwanaga K and Chibana K and Ota T and Nishii Y and Nakao A and Okada A and Hamai K and Sakai T and Harada T and Tanimura K and Yoshimine K and Tamura Y and Takaki R and Goto Y and Hibino M and Oba T and Sumi T and Kaneda H and Yamada T and Takayama K},
  year = {2026},
  journal = {International journal of clinical oncology},
  doi = {10.1007/s10147-026-03157-1},
  url = {https://doi.org/10.1007/s10147-026-03157-1}
}

RIS

TY  - JOUR
TI  - Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.
AU  - Nishioka N
AU  - Murata D
AU  - Azuma K
AU  - Ito K
AU  - Nomizo T
AU  - Yamada K
AU  - Imabayashi T
AU  - Iwanaga K
AU  - Chibana K
AU  - Ota T
AU  - Nishii Y
AU  - Nakao A
AU  - Okada A
AU  - Hamai K
AU  - Sakai T
AU  - Harada T
AU  - Tanimura K
AU  - Yoshimine K
AU  - Tamura Y
AU  - Takaki R
AU  - Goto Y
AU  - Hibino M
AU  - Oba T
AU  - Sumi T
AU  - Kaneda H
AU  - Yamada T
AU  - Takayama K
PY  - 2026
JO  - International journal of clinical oncology
DO  - 10.1007/s10147-026-03157-1
UR  - https://doi.org/10.1007/s10147-026-03157-1
ER  -

APA

N, N., D, M., K, A., K, I., T, N., K, Y., T, I., K, I., K, C., T, O., Y, N., A, N., A, O., K, H., T, S., T, H., K, T., K, Y., Y, T., R, T., Y, G., M, H., T, O., T, S., H, K., T, Y., & K, T. (2026). Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.. International journal of clinical oncology. https://doi.org/10.1007/s10147-026-03157-1

Source records

pubmed · retrieved 2026-09-25T19:08:15.003Z